Physician profile
Janet Lee
NPI 1366875213
$2,996.15
in general payments reported to CMS, 2019-2025
11 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $228 · 2021: $709 · 2022: $353 · 2023: $148 · 2024: $161 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $931.87 | 2019-2022 | |
| Alcon Vision LLC | $396.56 | 2022-2024 | Rocklatan, Hydrus Microstent |
| Ivantis, INC | $390.89 | 2021 | |
| Abbvie INC. | $367.73 | 2023-2025 | |
| Aerie Pharmaceuticals, INC. | $226.39 | 2019-2021 | |
| Nova Eye, INC. | $184.05 | 2025 | |
| Sight Sciences, INC. | $180.70 | 2019-2021 | |
| New World Medical,INC. | $169.76 | 2025 | Via360, Streamline, Kahook Dual Blade |
| Johnson & Johnson Surgical Vision, INC. | $101.43 | 2020 | |
| Rxsight INC | $24.48 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.